Pacira BioSciences to Present at the 2020 H.C. Wainwright 22nd Annual Global Investment Conference

Rhea-AI Summary

PARSIPPANY, N.J., Sept. 11, 2020 - Pacira BioSciences, Inc. (NASDAQ: PCRX) will present at the 2020 H.C. Wainwright 22^nd Annual Global Investment Conference on September 14, 2020, at 3:30 PM ET. Interested parties can listen to the live audio through the company’s website. A replay will be available for two weeks post-event. Pacira specializes in non-opioid pain management solutions, with its flagship product, EXPAREL®, launched in April 2012. The firm advocates for reduced opioid reliance in healthcare.

PARSIPPANY, N.J., Sept. 11, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will present at the 2020 H.C. Wainwright 22^nd Annual Global Investment Conference at 3:30 PM ET on Monday, September 14, 2020. Live audio of the virtual event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcast will also be available for two weeks following the event.

About Pacira                                                                           

Pacira BioSciences, Inc. (NASDAQ: PCRX) is a leading provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for health care practitioners and their patients. The company’s long-acting local analgesic, EXPAREL® (bupivacaine liposome injectable suspension) was commercially launched in the United States in April 2012. EXPAREL utilizes DepoFoam®, a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time.  In April 2019, the company acquired the iovera⁰ system, a handheld cryoanalgesia device used to deliver precise, controlled doses of cold temperature only to targeted nerves. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com.

Company Contact:
Pacira BioSciences, Inc.
Christian Pedetti
(973) 254-4387
Christian.pedetti@pacira.com

FAQ

When will Pacira BioSciences present at the H.C. Wainwright Global Investment Conference?

Pacira BioSciences will present on September 14, 2020, at 3:30 PM ET.

Where can I access the live audio of Pacira's presentation?

The live audio can be accessed on the 'Events' page of Pacira's website.

How long will the replay of Pacira's conference presentation be available?

The replay will be available for two weeks following the event.

What is Pacira's primary focus in pain management?

Pacira focuses on non-opioid pain management and regenerative health solutions.

What is EXPAREL® and when was it launched?

EXPAREL® is a long-acting local analgesic launched by Pacira in April 2012.